Candriam S.C.A.
Q3 2022 13F-HR Holdings
Net value change ($000)
+2,050,774
(16.9%)
New positions
140
Sold out positions
47
Turnover %
5.0%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q2 2022
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| AAPL | 203,502 | 46.7% |
| MSFT | 122,941 | 19.8% |
| TSLA | 96,149 | 102.2% |
| REGN | 56,941 | 25.8% |
| DAR | 54,466 | 142.8% |
| MELI | 51,678 | 388.8% |
| UNH | 44,384 | 22.2% |
| GOOGL | 43,657 | 43.2% |
| VERU | 43,561 | NEW |
| MA | 43,184 | 76.1% |
Top Reduces (Value $000, Stocks/ETFs)
| SQM | -48,581 | -53.5% |
| META | -42,756 | -67.4% |
| Turning Point Therapeutics, Inc. | -36,915 | -100.0% |
| Seagen Inc. | -36,397 | -26.4% |
| JNJ | -32,920 | -28.9% |
| BKNG | -26,726 | -72.2% |
| SYK | -23,618 | -68.1% |
| Sailpoint Technologies Holdings, Inc. | -23,583 | -100.0% |
| Biohaven Pharmaceutical Holding Co Ltd. | -21,044 | -100.0% |
| ADBE | -18,432 | -18.1% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
540
(0.0% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|